Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Axonics: Buy at the High?

TheMotleyFool

0 0

Axonics: Buy at the High?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Axonics (NASDAQ: AXNX) specializes in making medical devices to treat bladder and bowel dysfunction. It's the type of therapy that may be embarrassing to some, but the company's financial performance is nothing to be ashamed of.

On Monday, the stock hit its 52-week high of $74.45. Axonics' shares are up more than 49% this year. The reasons for the surge are simple: remarkable growth and the type of innovation that will support more of the same.

Image source: Getty Images.

Source Fool.com

Like: 0

AXNX

Share